Related Experiment Videos

Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis

S M Srinivasula1, M Ahmad, Y Guo

  • 1Center for Apoptosis Research and Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Cancer Research
|March 10, 1999
PubMed

Insights

Researchers identified caspase-9b, an apoptosis inhibitor. This alternatively spliced isoform of caspase-9 blocks apoptosis by preventing the formation of a functional Apaf-1-caspase-9 complex.

Area of Science:

  • Molecular Biology
  • Cell Biology

Background:

  • Alternative splicing generates protein isoforms with diverse functions.
  • Apoptosis regulators, like Bcl-x and Ich-1, can have opposing roles.
  • Caspase-9 is a key mediator of apoptosis.

Purpose of the Study:

  • To identify and characterize novel alternatively spliced isoforms of caspase-9.
  • To investigate the role of any identified isoforms in apoptosis regulation.

Main Methods:

  • Polymerase Chain Reaction (PCR) for detection.
  • mRNA and protein level analysis.
  • In vitro biochemical assays to assess protein interactions and enzymatic activity.

Main Results:

  • Identified an endogenous alternatively spliced isoform of caspase-9, named caspase-9b.
  • Caspase-9b lacks the central large subunit caspase domain.
  • Caspase-9b interacts with Apaf-1 and inhibits apoptosis.
  • Caspase-9b blocks Apaf-1-mediated activation of caspase-9 and caspase-3 in vitro.

Conclusions:

  • Caspase-9b functions as an endogenous inhibitor of apoptosis.
  • It interferes with the assembly of the Apaf-1-caspase-9 apoptosome complex.
  • This discovery reveals a new regulatory mechanism in apoptosis control.

Related Concept Videos